These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6197332)

  • 21. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
    Matozaki T; Martinez J; Williams JA
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of gastrin receptors on guinea pig pancreatic acini.
    Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
    Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of porcine gastrin-releasing peptide on amylase release, 2-deoxyglucose uptake, and alpha-aminoisobutyric acid uptake in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Endocrinology; 1983 Dec; 113(6):2106-12. PubMed ID: 6196181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study.
    von Schrenck T; Moran TH; Heinz-Erian P; Gardner JD; Jensen RT
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G512-21. PubMed ID: 3177648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feeding behavior response of Zucker rats to proglumide, a CCK receptor antagonist.
    McLaughlin CL; Peikin SR; Baile CA
    Pharmacol Biochem Behav; 1983 Jun; 18(6):879-83. PubMed ID: 6310643
    [No Abstract]   [Full Text] [Related]  

  • 33. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
    Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
    Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proglumide inhibition of trophic action of pentagastrin.
    Johnson LR; Guthrie PD
    Am J Physiol; 1984 Jan; 246(1 Pt 1):G62-6. PubMed ID: 6320664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
    Magous R; Bali JP
    Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F; Bani M; Cereda R; Chisté R; Pacini MA; Revel L; Rovati LA; Rovati LC; Setnikar I
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.